Nachrichten und Videos - GlobeNewsWire - Seite 5

Chiffre d’affaires 2 e trimestre 2023–2024 : - 1,8 % Des ventes contrastées selon les activités Chiffre d'affaires T2 (janvier 2024–mars 2024) 2022–2023 2023–2024 Variation à données publiées Variation à tcpc* Publié Publié Millions € % Millions € % PULVÉRISATION AGRICOLE 147,7 157,4 + 9,7 + 6,5 % + 12,0 + 8,1 % ARRACHAGE DE BETTERAVES 34,3 17,1 - 17,2 - 50,1 % - 17,1 - 49,9 % LOISIRS 48,4 47,4 - 1,0 - 2,0 % - 4,4 - 9,0 % INDUSTRIE 67,6 70,7 + 3,1 + 4,7 % + 3,3 + 4,9 %...

Oslo, Norway, 24 th of April 2024 Vistin Pharma ASA (VISTN) today announces the financial results for the first quarter of 2024. Revenue in the first quarter ended at MNOK 104 compared to MNOK 101 in Q1 2023. Sales volume in the quarter was up by 11% compared to Q1 2023. First quarter EBITDA ended at MNOK 20 compared to MNOK 14 in Q1 2023, representing a 45% increase. EBITDA positively affected by increased sales volume and product mix, partly offset by a one-time inventory adjustment of MNOK 7....

Company Announcement No. 1104 The Board of Directors of DSV A/S has decided to exercise the authority to buy back shares granted by the Annual General Meeting on 14 March 2024. The authority is valid until 14 March 2029 and covers a maximum of 21,400,000 shares. Purpose The purpose of the share buyback is to adjust the capital structure and meet obligations relating to the Group’s share-based incentive programmes. At a General Meeting of DSV A/S, a resolution will be proposed that any shares...

Company Announcement No. 1103 Selected key figures and ratios for the period 1 January – 31 March 2024 Q1 2024 Q1 2023 Key figures (DKKm) Revenue 38,340 40,954 Gross profit 10,265 11,391 Operating profit (EBIT) before special items 3,641 4,672 Profit for the period 2,393 3,287 Adjusted earnings for the period 2,463 3,340 Ratios Conversion ratio 35.5% 41.0% Diluted adjusted earnings per share of DKK 1 for the last 12 months 55.3 76.9 Jens H. Lund, Group CEO: “In a normalising market, we are...

Press release Paris, 24 April 2024 Financial results at 31 March 2024 Good start to the year, strong momentum on “Lead the Future” Creation of MASORANGE, new leader in Spain Acceleration of revenue and EBITDAaL growth in the first quarter Confirmation of 2024 targets In millions of euros 1Q 2024 1Q 2023 comparable basis 1Q 2023 historical basis change comparable basis change historical basis Revenues 9,850 9,649 9,517 2.1 % 3.5 % EBITDAaL 2,406 2,351 2,306 2.3 % 4.3 % eCAPEX (excluding...

BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 23 Apr 2024. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 27.8695 £ 24.9583 Estimated MTD return 1.15 % 1.25 % Estimated YTD return 1.17 % 1.58 % Estimated ITD return 178.69 % 149.58 % NAV and returns are calculated net of management and performance fees Market information Euro Shares Amsterdam...

ENDEAVOUR ANNOUNCES TRANSACTION IN OWN SHARES London, 24 April 2024 – Endeavour Mining plc (LSE:EDV, TSX:EDV) (“the Company”) announces it has purchased the following number of its ordinary shares of USD 0.01 each from Stifel Nicolaus Europe Limited. Aggregated information Dates of purchase: 23 April 2024 Aggregate number of ordinary shares of USD 0.01 each purchased: 29,500 Lowest price paid per share (GBp): 1,646.00 Highest price paid per share (GBp): 1,675.00 Volume weighted average...

Nasdaq Copenhagen London Stock Exchange Euronext Dublin Other stakeholders 24 April 2024 Ringkjøbing Landbobank’s quarterly report for the first quarter of 2024 The bank’s board of directors and general management today approved the quarterly report for the first quarter of 2024. The bank delivers core earnings of DKK 793 million and net profit of DKK 616 million in the first quarter of the year. The net profit is equivalent to a 24% p.a. return on equity. Core earnings (DKK million) Q1...

BOUSSARD & GAVAUDAN HOLDING LIMITED Ordinary Shares The Directors of Boussard & Gavaudan Holding Limited would like to announce the following information for the Company. Close of business 23 Apr 2024. Estimated NAV Euro Shares Sterling Shares Estimated NAV € 27.8695 £ 24.9583 Estimated MTD return 1.15 % 1.25 % Estimated YTD return 1.17 % 1.58 % Estimated ITD return 178.69 % 149.58 % NAV and returns are calculated net of management and performance fees Market information Euro Shares Amsterdam...

Press Release Nicox: Second notice of the Ordinary and Extraordinary Shareholders' Meeting on May 6, 2024 and appointment of an ad hoc agent April 24, 2024 – release at 07:30 CET Sophia Antipolis, France Nicox SA (Euronext Growth Paris: FR0013018124, ALCOX), an international ophthalmology company, informs its shareholders that the Ordinary and Extraordinary General Meeting, having been unable to deliberate on April 10, 2024 as the quorum required by law has not been reached, will be held, on...

Continued Group service revenue growth (+3.6% y-on-y), mainly driven by Consumer (+4.5%) and Business (+3.2%) Ongoing positive net adds in Consumer postpaid +30k and broadband +13k, of which 8k related to Kabeltex acquisition Expanded fiber footprint with +130k HP in Q1 2024 (+159k HP including Glaspoort) Adj. EBITDA AL of € 605m (+3.6% y-on-y), quarterly FCF generation impacted by intra-year phasing ACM unconditionally approved Youfone acquisition, transaction closed on 4 April Full year 2024...

PARIS, FRANCE, 24 avril 2024 - Ipsen (Euronext : IPN ; ADR : IPSEY), groupe biopharmaceutique mondial de spécialité, publie aujourd’hui son chiffre d’affaires pour le premier trimestre 2024. Q1 2024 Q1 2023 % change €m €m Réalisé TTC 1 Plateforme de croissance 2 509,7 452,0 12,8% 16,2% Nouveaux médicaments 3 45,5 14,3 n/a n/a Somatuline ® 257,8 263,2 -2,0% -1,3% Autres 9,5 12,4 -23,8% -20,5% Chiffre d’affaires Groupe 822,4 741,9 10.9% 13.3% Faits marquants Croissance des ventes...

Recognition given for achievement in commercializing Joenja® (leniolisib), a first-in-class medication brought to market 10 years after disease state, APDS, was first characterized Leiden, the Netherlands, April 24, 2024: Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is pleased to announce its recognition as an Industry Innovator by the National Organization for Rare Disorders (NORD®) at the Rare Impact Awards on June 8, 2024. The Rare...

PRESS RELEASE - PRIVILEGED INFORMATION In view of the restructuring plan announced on April 11, 2024, BioSenic has decided to postpone the publication of its 2023 annual report as well as its annual general meeting of shareholders, so that the Enterprise Court of Nivelles can make a decision before the completion of the annual formalities. The Company believes that this postponement is preferable to ensure that the financial statements can be prepared on a going concern basis....

La Hulpe, Belgium – 24 April 2024, 7:00 a.m. CET – Unifiedpost Group SA (Euronext Brussels: UPG) (“Unifiedpost”), a leader in cloud-based business process solutions, will present an overview of its mid-term strategy on Tuesday, 30 April 2024. The event will take place from 2:00pm to 4:00pm CET on Tuesday, 30 April 2024. The presenting team will be Hans Leybaert, CEO, Koen De Brabander, CFO, and some of the group’s business leaders. The agenda for the day is as follows: Introductions...

OSLO, Norway (24 April 2024) - TGS will release its Q1 2024 results at approximately 07:00 CEST on 8 May 2024. CEO Kristian Johansen and CFO Sven Børre Larsen will present the results at 09:00 CEST at House of Oslo, Ruseløkkveien 34, Oslo, Norway. The presentation is open to the public and can be followed live online. Access and registration for online attendees are available by copying and pasting this link into your browser: https://channel.royalcast.com/landingpage/hegnarmedia/20240508_16/...

Hydro’s adjusted EBITDA for the first quarter of 2024 was NOK 5,411 million, down from NOK 7,525 million for the same quarter last year. Lower aluminium sales prices, Extrusions volumes and recycling margins, and higher fixed costs negatively impacted results, partly offset by lower raw material costs. This resulted in an adjusted RoaCE of 5.6 percent over the last twelve months. Results down on weaker demand and recycling margins, revenue drivers increasing Increasing recycling and...

The Netherlands, 24 April 2024 Vopak reports strong Q1 2024 results and increases FY 2024 outlook Key highlights Q1 2024 Improve Increased net profit -including exceptional items 1 - in Q1 2024 to EUR 106 million, an improvement of 3% year-on-year, driven by favorable storage demand across different geographies and markets Increased proportional EBITDA -excluding exceptional items 1 - in Q1 2024 to EUR 298 million, an improvement of 9% year-on-year when adjusted for divestment impacts of EUR 21...

WithSecure Corporation, Interim report release 1 January – 31 March 2024, 24 April 2024 at 8.00 EEST WithSecure Interim report 1 January – 31 March 2024: Elements Company profitability developing positively, despite slow start of the year Highlights of January – March 2024 (“first quarter”) Annual Recurring Revenue (ARR) (1) for Elements Cloud (2) increased by 10% to EUR 80.5 million (EUR 73.4 million) Elements Cloud ARR increase from previous quarter was 3% Net Revenue Retention for...

Bon début d’année 2024 _ COMMUNIQUÉ DE PRESSE _ Chiffre d’affaires standard de 1 692 millions d’euros au premier trimestre 2024, en croissance organique de +2,8 % par rapport à la même période de 2023 et de +4,7 % hors Autres activités Croissance organique de +6,7 % des activités d'Electrification, reflétant une croissance à deux chiffres de l’activité Production d’énergie & Transmission et une accélération globale des tendances dans l'électrification Carnet de commandes...